UPDATE : Monday, September 7, 2020
상단여백
Intron Bio secures new drug substance for bacterial pneumonia
Intron Biotechnology said Monday that it has secured a new drug substance, ...
by Shim Hyun-tai  |  2020-08-24 18:01
라인
GC Pharma collects more plasma to speed up work on Covid-19 treatment
GC Pharma said it would collect more plasma from recovered Covid-19 patient...
by Kim Chan-hyuk  |  2020-08-24 17:15
라인
Regulator OKs Pfizer’s cardiomyopathy drug Vyndamax
The Ministry of Food and Drug Safety has approved Pfizer's Vyndamax (in...
by Shim Hyun-tai  |  2020-08-24 16:12
라인
Genexine begins global P3 trial of anemia drug
Genexine said Monday that the company has begun administering its long-acti...
by Shim Hyun-tai  |  2020-08-24 16:12
라인
Despite fall in new virus cases, calls rise for tightest social distancing
New virus cases dropped below 300 on Monday, but epidemiological experts ca...
by Shim Hyun-tai  |  2020-08-24 15:42
라인
Korea’s healthcare exports expand 36% in July
The nation’s exports of healthcare products rose 36 percent in July from a ...
by Kwak Sung-sun  |  2020-08-24 14:54
라인
‘Daily confirmed cases could hit 2,800 in 2 weeks if left uncontrolled’
The health authorities must implement the toughest social distancing to con...
by Song Soo-youn  |  2020-08-24 11:39
라인
Korea at crossroads of nationwide epidemic, expands tighter restrictions to whole country
Korea’s new virus cases exceeded 300 for two consecutive days on Saturday, ...
by Shim Hyun-tai  |  2020-08-22 19:08
라인
Seoul using near 80% of Covid-19 sickbeds
Out of the 1,118 sickbeds for the Covid-19 patients in the Seoul metro regi...
by Shim Hyun-tai  |  2020-08-21 18:10
라인
Korea going all out to import, develop Covid-19 vaccines, treatments
As global competition heats up to secure the Covid-19 vaccines, the Korean ...
by Shim Hyun-tai  |  2020-08-21 16:06
라인
Drug sales reps refrain from visiting doctors amid Covid-19 resurge
An increasing number of pharmaceutical companies are holding the activities...
by Kim Yun-mi  |  2020-08-21 16:00
라인
Hanmi terminates global P2 trial for poziotinib
Hanmi Pharmaceutical has terminated its global phase 2 clinical trial for p...
by Lee Han-soo  |  2020-08-21 15:56
라인
‘Metastatic pancreatic cancer needs insurance benefit for Onyvide+5-FU/LV’
Patients with metastatic pancreatic cancer, notorious for high fatality, ne...
by Kim Yun-mi  |  2020-08-21 15:21
라인
New virus cases top 300; tighter restrictions eyed in greater Seoul
Korea's daily Covid-19 cases surpassed 300 as community outbreaks conti...
by Lee Han-soo  |  2020-08-21 14:29
라인
‘Almost all patients with aortic stenosis will get TAVI by 2025’
“In the PARTNER 3 clinical trial for low-risk patients, Transcatheter Aorti...
by Kim Chan-hyuk  |  2020-08-21 14:24
라인
Samsung Bioepis wins European nod for Avastin biosimilar
Samsung Bioepis said that it has obtained a sales approval for Aybintio, a ...
by Lee Han-soo  |  2020-08-21 11:32
라인
Daewoong to co-develop esophagitis drug for treating Covid-19
Daewoong Pharmaceutical signed an agreement with Institut Pasteur Korea (IP...
by Shim Hyun-tai  |  2020-08-20 18:41
라인
Korea speeds up developing coronavirus-related products
The government plans to accelerate the development of Covid-19 diagnostic k...
by Shim Hyun-tai  |  2020-08-20 17:58
라인
Bioneer to donate 10,000 Covid-19 test kits to Lebanon
Korean biotech company Bioneer said it would donate 10,000 Covid-19 diagnos...
by Kim Chan-hyuk  |  2020-08-20 17:01
라인
Yuhan licenses out gastrointestinal treatment to US partner
Yuhan Corp. said that it has licensed out YH12852, a gastrointestinal motil...
by Lee Han-soo  |  2020-08-20 16:58
여백
여백
여백
Back to Top